2.62 USD
↘ 0.05 (1.87%)AT CLOSE (11:59 AM EDT)
Organogenesis Holdings Inc. Class A Common Stock
ORGONASDAQ • USD
2.63
↗ 0.00 (0.19%)
POST MARKET (AS OF 04:19 PM EDT)
Post Market
AS OF 04:19 PM EDT
2.63
↗ 0.00 (0.19%)
Market: OPEN
ORGO is currently priced at $2.49. The technical outlook is "Buy" and the fundamental picture shows "Neutral". This is driven by a weak Piotroski F-Score of 1/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest ORGO is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Jul 17, 2026.
Open?$2.61
High?$2.69
Low?$2.58
Prev. Close?$2.67
Volume?542.8K
Avg. Volume?801.5K
VWAP?$2.62
Rel. Volume?0.68x
Bid / Ask
Bid?$2.21 × 100
Ask?$3.08 × 100
Spread?$0.87
Midpoint?$2.65
Valuation & Ratios
Market Cap?343.6M
Shares Out?128.7M
Float?71.9M
Float %?55.9%
P/E Ratio?N/A
P/B Ratio?1.40
EPS?-$0.12
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
Employees
854
Market Cap
343.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2016-11-29
Address
85 DAN ROAD
CANTON, MA 02021
Phone: 781-575-0775
CANTON, MA 02021
Phone: 781-575-0775
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?64
Momentum?97
Short Sent.?34
Piotroski F-Score?1/9Weak
Altman Z-Score?2.78Grey
Confidence?51%Low
Short InterestVery High
Short % of Float?19.19%High
Short Interest?13.8M
Days to Cover?16.3
Free Float71.9M
Avg Daily Volume846.0K
Settlement Date2026-06-30
Financial Health
Current Ratio?3.49Strong
Quick Ratio?3.12Strong
Cash Ratio?1.20Strong
Debt/Equity?0.16Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score93/100
P/E?N/A▾
P/B?1.40CHEAP▾
Peers100
S&P89
P/S?0.67CHEAP▾
Peers100
S&P92
P/FCF?20.1FAIR▾
Peers100
S&P55
EV/EBITDA?9.3CHEAP▾
Peers100
S&P85
EV/Sales?0.57CHEAP▾
Peers100
S&P97
Returns & Efficiency
ROE?-6.4%WEAK▾
S&P10
ROA?-3.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$17.1M
Enterprise Value?$292.0M
Fundamentals ratios updated end of day